Search Results 761-770 of 16985 for monoclonal antibody
Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...
Monoclonal antibody treatment for multiple myeloma within 21 days;; Cytotoxic therapy within 14 days;; Proteasome inhibitor therapy within 14 days ...
History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...
... antibody-targeted chemotherapeutics. Research aims. The Grohne Cancer ... Aim 2: The purpose of this aim is to develop innovative immune interventions using ...
An immunoglobulin is an antibody produced by immune system cells to fight bacteria, parasites and other agents that cause illness. IgA antibodies circulate ...
... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 Rochester, MN.
Patients who have received prior PD-1/PD-L1 monoclonal antibodies in any disease setting are eligible. ... antibody agent, ASTX727 is a hypomethylating ...
... monoclonal antibody and B-cell maturation antigen (BCMA)-directed therapy * Cohort D: Newly diagnosed multiple myeloma per IMWG with a history of 4 to 8 ...
The purpose of this study is to determine whether an EHT approach to DMT, defined as use of one of five monoclonal antibodies (alemtuzumab, natalizumab ...
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.